Organization:Pharmacogene Variation Consortium
From HandWiki
Content | |
---|---|
Description | The PharmVar Consortium |
Data types captured | Pharmacogenomics and Pharmacogenetics |
Organisms | Human |
Contact | |
Research centre | Children's Mercy Hospital |
Primary citation | PMID 29134625 |
Release date | 2017 |
Access | |
Website | www |
Download URL | www |
Web service URL | www |
Miscellaneous | |
Curation policy | Yes |
Pharmacogene Variation Consortium (abbreviated as PhamVar) is an international group of experts that maintains a systematic nomenclature system for allelic variations of genes that affect the metabolism of drugs.[1][2]
The database is focused on cytochrome P450 enzymes, but is being expanded into other classes of enzymes. The original nomenclature was maintained by the Human CYP Allele Nomenclature Database. However PhamVar took over this function in 2017.[3]
See also
- PharmGKB
- pharmacogenetics
- pharmacogenomics
- pharmacokinetics
- pharmacodynamics
- Clinical Pharmacogenetics Implementation Consortium
References
- ↑ "The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database". Clinical Pharmacology and Therapeutics 103 (3): 399–401. March 2018. doi:10.1002/cpt.910. PMID 29134625.
- ↑ "The Evolution of PharmVar". Clinical Pharmacology and Therapeutics 105 (1): 29–32. January 2019. doi:10.1002/cpt.1275. PMID 30536702.
- ↑ "Cytochrome P450 in Pharmacogenetics: An Update". Pharmacogenetics. Advances in Pharmacology. 83. San Diego, Calif.. 2018. pp. 3–32. doi:10.1016/bs.apha.2018.04.007. ISBN 9780128133811.
Original source: https://en.wikipedia.org/wiki/Pharmacogene Variation Consortium.
Read more |